Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | RVMD | HALO | ||
| Company | Arena Pharmaceuticals | Revolution Medicines Inc | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.97 | 44.00 | 47.25 | ||
| High | 100.00 | 44.42 | 47.63 | ||
| Low | 99.97 | 43.49 | 46.76 | ||
| Last | 99.99 | 44.39 | 47.54 | ||
| Change | +0.06 | +0.46 | +0.38 | ||
| % Change | +0.06% | +1.05% | +0.81% | ||
| Volume | 5,718,500 | 350,000 | 308,600 | ||
| 20-Day Average Volume | 1,676,465 | 2,063,085 | 1,353,735 | ||
| Previous Close | 99.93 | 43.93 | 47.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 47.90 | 48.02 | ||
| 20-Day Raw Stochastic | 99.86% | 10.82% | 36.26% | ||
| 20-Day Relative Strength | 75.07% | 37.57% | 43.67% | ||
| Weighted Alpha | -14.40 | +40.55 | +26.47 | ||
| Today's Opinion | 100% Buy | 8% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | -1.71% since 12/17/24 | -2.18% since 12/17/24 | ||
| Low | 93.54 on 03/07/22 | 42.53 on 12/20/24 | 46.26 on 12/23/24 | ||
| High | 100.00 on 03/10/22 | 45.77 on 12/18/24 | 49.60 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | -21.78% since 11/22/24 | -2.98% since 11/22/24 | ||
| Low | 92.85 on 02/22/22 | 42.53 on 12/20/24 | 46.26 on 12/23/24 | ||
| High | 100.00 on 03/10/22 | 59.72 on 11/26/24 | 50.00 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | -0.02% since 09/24/24 | -15.41% since 09/24/24 | ||
| Low | 89.03 on 01/25/22 | 42.53 on 12/20/24 | 42.01 on 11/18/24 | ||
| High | 100.00 on 03/10/22 | 62.40 on 11/11/24 | 62.13 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | +15.30% since 06/24/24 | -8.68% since 06/24/24 | ||
| Low | 48.12 on 12/06/21 | 36.50 on 07/05/24 | 42.01 on 11/18/24 | ||
| High | 100.00 on 03/10/22 | 62.40 on 11/11/24 | 65.53 on 08/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 7,467,241 | 6,048,371 | ||
| Shares Outstanding, K | 61,659 | 168,219 | 127,227 | ||
| Annual Sales | 50,000 | 11,580,000 | 829,250,000 | ||
| Annual Net Income | -616,430,000 | -436,370,000 | 281,590,000 | ||
| Last Quarter Sales | 50,000 | 0 | 290,080,000 | ||
| Last Quarter Net Income | -155,610,000 | -156,290,000 | 137,010,000 | ||
| 60-Month Beta | 0.55 | 1.40 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | -0.94 on 11/06/24 | 1.27 on 10/31/24 | ||
| Latest Earnings Date | 05/04/22 | 11/06/24 | 02/18/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 13.55 | ||